Standard Treatment Recommendations for Advanced Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECs)

被引:0
|
作者
Smith, Abraham T. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
来源
JOURNAL OF THE PANCREAS | 2022年 / 23卷 / 07期
关键词
Pancreas; Pancreatitis; Pancreatic cell electrical activity; Insulin secretion;
D O I
10.35841/1590-8577-23.7.757
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NETs), also known as carcinoids and islet cell tumours, are tumours produced from neuroendocrine cells that can arise anywhere along the gastrointestinal system. They are a diverse family of neoplasms with a broad and complex clinical range. Neuroendocrine tumours are tumours that arise in neuroendocrine cells, which are specialized cells. Neuroendocrine cells share characteristics with nerve cells and hormone-producing cells. Neuroendocrine tumours are uncommon and can develop anywhere in the body. Endocrinol cells found in the gastroenteric mucosa as well as those found in the pancreas, mostly comprising islets of Langerhans, are referred to as Gastroenteropancreatic (GEP) endocrine cells.
引用
收藏
页码:68 / 69
页数:2
相关论文
共 50 条
  • [1] Clinico-Pathologic and Survival Analysis of 211 Gastroenteropancreatic G3 Neuroendocrine Carcinomas (GEP-NECs)
    Milione, Massimo
    Pellegrinelli, Alessio
    Maisonneuve, Patrick
    Spada, Francesca
    Spaggiari, Paola
    Albarello, Luca
    Barberis, Massimo
    Vanoli, Alessandro
    Vittorio, Perfetti
    Roberto, Buzzoni
    Pusceddu, Sara
    Concas, Laura
    Martinelli, Barbara
    Antelmi, Ester
    Carnaghi, Carlo
    Manzoni, Marco
    Fazio, Nicola
    Sessa, Fausto
    Solcia, Enrico
    Capella, Carlo
    La Rosa, Stefano
    MODERN PATHOLOGY, 2015, 28 : 138A - 138A
  • [2] Clinico-Pathologic and Survival Analysis of 211 GastroEnteroPancreatic G3 Neuroendocrine Carcinomas (GEP-NECs)
    Milione, M.
    Spada, F.
    Maisonneuve, P.
    Pusceddu, S.
    Spaggiari, P.
    Barberis, M.
    Albarello, L.
    Vanoli, A.
    Manzoni, M. F.
    Carnaghi, C.
    Fazio, N.
    Mazzaferro, V.
    Capella, C. R.
    La Rosa, S.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 102 - 103
  • [3] Clinico-Pathologic and Survival Analysis of 211 Gastroenteropancreatic G3 Neuroendocrine Carcinomas (GEP-NECs)
    Milione, Massimo
    Pellegrinelli, Alessio
    Maisonneuve, Patrick
    Spada, Francesca
    Spaggiari, Paola
    Albarello, Luca
    Barberis, Massimo
    Vanoli, Alessandro
    Vittorio, Perfetti
    Roberto, Buzzoni
    Pusceddu, Sara
    Concas, Laura
    Martinelli, Barbara
    Antelmi, Ester
    Carnaghi, Carlo
    Manzoni, Marco
    Fazio, Nicola
    Sessa, Fausto
    Solcia, Enrico
    Capella, Carlo
    La Rosa, Stefano
    LABORATORY INVESTIGATION, 2015, 95 : 138A - 138A
  • [4] Microsatellite Unstable Neuroendocrine Carcinomas (NECS) Are a Distinct Clinico-Pathologic Category of NECS in the Gastroenteropancreatic System
    Sahnane, N.
    Monti, M.
    Furlan, D.
    Vicari, E.
    Vanoli, A.
    Capella, C.
    Solcia, E.
    Sessa, F.
    La Rosa, S.
    LABORATORY INVESTIGATION, 2014, 94 : 201A - 201A
  • [5] Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): A critical view
    Fazio, Nicola
    Spada, Francesca
    Giovannini, Monica
    CANCER TREATMENT REVIEWS, 2013, 39 (03) : 270 - 274
  • [6] Microsatellite Unstable Neuroendocrine Carcinomas (NECS) Are a Distinct Clinico-Pathologic Category of NECS in the Gastroenteropancreatic System
    Sahnane, N.
    Monti, M.
    Furlan, D.
    Vicari, E.
    Vanoli, A.
    Capella, C.
    Solcia, E.
    Sessa, F.
    La Rosa, S.
    MODERN PATHOLOGY, 2014, 27 : 201A - 201A
  • [7] Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Inbal Uri
    Simona Grozinsky-Glasberg
    Clinical Diabetes and Endocrinology, 4 (1):
  • [8] Polish recommendation for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors (GEP NET)
    Kos-Kudla, Beaty
    ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (02): : 73 - 78
  • [9] Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas
    Butt, B. P.
    Stokmo, H. L.
    Ladekarl, M.
    Tabaksblat, E. Mitkina
    Sorbye, H.
    Revheim, M. E.
    Hjortland, G. O.
    ANNALS OF ONCOLOGY, 2021, 32 : S915 - S915
  • [10] Morphological Differentiation and Ki67-Index Are Predictive of Prognosis Independently of the Type of Therapy in Gastroenteropancreatic Neuroendocrine Carcinomas (NECs)
    Milione, M.
    Maisonneuve, P.
    Spada, F.
    Pellegrinelli, A.
    Spaggiari, P.
    Albarello, L.
    Pisa, E.
    Vanoli, A.
    Pusceddu, S.
    Buzzoni, R.
    Concas, L.
    Capella, C.
    Solcia, E.
    Fazio, N.
    La Rosa, S.
    NEUROENDOCRINOLOGY, 2016, 103 : 40 - 40